Gallagher Kathleen P. bought RNA
April 20, 2026 · Form 4 insider transaction
Gallagher Kathleen P. bought 205,000 shares of Atrium Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
205,000
Price
$0.00
Total value
N/A
InsiderGallagher Kathleen P.
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 20, 2026
Filing dateApril 22, 2026
Shares owned after205,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Twenty-five percent (25%) of the shares underlying this option shall vest and become exercisable on March 20, 2027, with the remaining shares vesting in thirty-six (36) substantially equal monthly installments each month thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.